Udayavni Special

AstraZeneca promises Covid-19 vaccine at cost price worldwide


PTI, Nov 24, 2020, 11:26 AM IST

Paris: Hopes of an effective vaccine against coronavirus becoming available rose again on Monday with AstraZeneca and Oxford University claiming success with their product, becoming the third team to do so.

The head of AstraZeneca in France, Olivier Nataf, answered questions from AFP in an interview, saying that the data were very encouraging.

The 70 per cent rate is the result of a combined analysis.

Using a regimen of first injecting half a dose of the vaccine and then a full dose a month later the effectiveness was 90 per cent.

Another system, of one full dose first and another a month later the effectiveness is 62 per cent.

This is an interesting lesson: the half-dose plus one dose scheme can become something that we follow, there is an opportunity for availability for the population, where it would take fewer doses to vaccinate more people.

The second point to remember is that there is 100 per cent protection against the occurrence of severe forms of illness and hospitalisations in participants who received the vaccine. And the last point is the confirmation of safety: no serious side effects have been reported, the vaccine is well tolerated in both dosing regimens.

Finally, there is greater simplicity in storage, transport, handling, under normal refrigeration conditions of 2 to 8 degrees. This is a very interesting element from the public health standpoint.

We will be producing three billion doses worldwide in 2021.

Parallel and independent supply chains were set up very early on: in the United States, in several European countries and in the rest of the world.

Production is underway. We have announced the first agreements with various governments and non-governmental organisations.

It will be possible to provide the vaccine as soon as the final results of clinical trials, and especially the evaluations by health authorities, are available.

Production is ramping up, there are already 50 million doses of active substances available and capacity is being increased almost weekly.

It’s more than a strategy, it’s a commitment.

The price is around 2.50 euros ($3) per dose. This is the main subject of our agreement with Oxford, in order to be able to provide this vaccine to the widest possible population, under the most equitable conditions of access possible.

We are committed to these three billion doses at cost price for 2021. We must not forget that this is a race against the virus rather than a race for the vaccine between competitors.

As an industrialist, I hear this a lot, but in fact there are a lot of collaborations in this race against the virus: Pfizer has partnered with BioNtech, Sanofi with GSK, AstraZeneca with the University of Oxford.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

K’taka COVID-19 update: 324 new cases, 890 recoveries, 3 deaths on Jan 21

IPL auction likely on February 18: BCCI official

Ph 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

Cong to elect party president by June 2021: CWC

Govt asks farm leaders to reconsider proposal for suspending three laws; Unions stick to repeal demand

‘Paytm Cashback offer’: LPG cylinder from HP, Indane and Bharat gas for free

Former CJI Gogoi provided ‘Z+’ VIP security cover


Related Articles More

K’taka COVID-19 update: 324 new cases, 890 recoveries, 3 deaths on Jan 21

Arthritis drug no better than standard care for severe COVID-19, says study

Oxford preparing COVID-19 vaccine versions to fight virus variants: Report

Covid-19 vaccination: Karnataka reports 463 adverse events

K’taka COVID-19 update: 501 new cases, 665 discharges, 4 deaths on Jan 19

MUST WATCH

Mangaluru: Police arrest nine students for alleged ragging

Remembering Netaji Subhas Chandra Bose | Asha Raghuvamshi

Inter-state Ganja smuggling racket busted: 7 held, 44.630 kgs of Marijuana seized

explosion sound around shivamogga

Mangaluru harassment in bus case: Young woman narrates her ordeal

Latest Additions

K’taka COVID-19 update: 324 new cases, 890 recoveries, 3 deaths on Jan 21

Ladakh to make debut in Republic Day Parade on Rajpath

K’taka farmers to hold tractor rally in Bengaluru on Republic Day

Replica of Ram Temple, Ayodhya’s heritage to be showcased in Uttar Pradesh’s Republic day tableau

IndiGo to start flights to Agra from Bengaluru, Bhopal on March 28

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.